Maxigen Biotech Stock

Maxigen Biotech EBIT

The EBIT of Maxigen Biotech (1783.TW) as of Aug 10, 2026 is 261.04 M TWD. In the previous year, EBIT was 194.38 M TWD — a change of 34.30% (higher).

EBIT

261.04 MTWD

YoY

34.30%

Last updated:

In 2026, Maxigen Biotech's EBIT was 261.04 M TWD, a 34.30% increase from the 194.38 M TWD EBIT recorded in the previous year.

The Maxigen Biotech EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M TWD)
Date
EBIT (M TWD)
Jan 1, 2021
100.69 base
Jan 1, 2022
170.56 base
Jan 1, 2023
149.85 base
Jan 1, 2024
194.38 base
Jan 1, 2025
261.04 base
Jan 1, 2026 (e)
120.50 base
Jan 1, 2027 (e)
118.14 base
Jan 1, 2028 (e)
124.44 base
YEAREBIT (M TWD)
2028 est 124.44
2027 est 118.14
2026 est 120.50
2025 261.04
2024 194.38
2023 149.85
2022 170.56
2021 100.69
2020 76.89
2019 76.10
2018 50.15
2017 21.05
2016 -7.15
2015 -60.52
2014 -28.60
2013 -3.56
2012 -10.67
2011 -41.64
2010 -30.93
2009 7.31
2008 -31.50
Access this data via the Eulerpool API

Maxigen Biotech Revenue

Maxigen Biotech Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
511.98 M TWD
100.69 M TWD
87.67 M TWD
Jan 1, 2022
604.43 M TWD
170.56 M TWD
139.40 M TWD
Jan 1, 2023
622.12 M TWD
149.85 M TWD
165.83 M TWD
Jan 1, 2024
680.65 M TWD
194.38 M TWD
190.17 M TWD
Jan 1, 2025
811.56 M TWD
261.04 M TWD
265.31 M TWD
Jan 1, 2026 (e)
459.00 M TWD
120.50 M TWD
75.58 M TWD
Jan 1, 2027 (e)
450.00 M TWD
118.14 M TWD
73.25 M TWD
Jan 1, 2028 (e)
474.00 M TWD
124.44 M TWD
77.92 M TWD

Maxigen Biotech Margins

Maxigen Biotech stock margins

The Maxigen Biotech margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Maxigen Biotech. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Maxigen Biotech.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
50.98 %
19.67 %
17.12 %
Jan 1, 2022
61.88 %
28.22 %
23.06 %
Jan 1, 2023
68.17 %
24.09 %
26.66 %
Jan 1, 2024
71.01 %
28.56 %
27.94 %
Jan 1, 2025
69.46 %
32.17 %
32.69 %
Jan 1, 2026 (e)
69.46 %
26.25 %
16.47 %
Jan 1, 2027 (e)
69.46 %
26.25 %
16.28 %
Jan 1, 2028 (e)
69.46 %
26.25 %
16.44 %

Maxigen Biotech Stock analysis

What does Maxigen Biotech do? Maxigen Biotech Inc is a biotechnology company that was founded in 2000. The company, based in San Francisco, California, specializes in the development and production of biotechnological products and solutions. The company's goal is to lead in the biotechnology industry and have a positive impact on the health and well-being of people. To achieve its goals, the company has specialized in four business areas. The first business area is the research and development of new biotechnological products. The company has a team of scientists who work continuously on new innovative technologies and products. The company has already brought several products to market that have been very successful in the biotechnology industry. The second business area is the production of biotechnological products. The company has its own production facility equipped with state-of-the-art technologies. Here, the company's products are manufactured and delivered to customers worldwide. The third business area is the distribution of biotechnological products. The company has built a large distribution network to distribute its products in different parts of the world. The company works closely with pharmacies, laboratories, and hospitals to ensure that its products are made accessible to people. The fourth business area is the application of biotechnological products. The company works closely with doctors and healthcare facilities to ensure that its products are used in medical practice. The company is committed to using its products to improve the health and well-being of people worldwide. Maxigen Biotech Inc has introduced some remarkable products to the market in its history. One of the company's most important products is a highly effective antibiotic used to fight bacterial infections. The company has also developed a medication for the treatment of hypertension that is in high demand worldwide. Additionally, the company has developed a range of products for the treatment of cancer and other serious illnesses. The company has also made a significant contribution to public health. The company has developed technology to lower cholesterol levels in the blood, which can help prevent cardiovascular diseases. The company has also worked on the development of vaccines against infectious diseases that are still prevalent in some regions of the world. Maxigen Biotech Inc has received numerous awards and recognition in its history. The company is known for its innovation and high quality in the production of its products. The company is an example of how the biotechnology industry can contribute to improving the health and well-being of people worldwide. In summary, Maxigen Biotech Inc is a biotechnology company that specializes in the development and production of biotechnological products and solutions. The company has specialized in four business areas: research and development of new products, production of biotechnological products, distribution of biotechnological products, and application of biotechnological products. The company has introduced some remarkable products to the market in its history and has made a significant contribution to public health. The company has received numerous awards and recognition and is an example of excellence in the biotechnology industry. Maxigen Biotech is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Maxigen Biotech's EBIT

Maxigen Biotech's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Maxigen Biotech's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Maxigen Biotech's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Maxigen Biotech’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Maxigen Biotech stock

EBIT of Maxigen Biotech is 261.04 M TWD in 2026.

EBIT of Maxigen Biotech changed from 194.38 M TWD to 261.04 M TWD, representing a 34.30% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Maxigen Biotech since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Maxigen Biotech historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Maxigen Biotech

All Key Metrics — Maxigen Biotech